SonoScape Medical

SonoScape Medical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SonoScape Medical (300633.SZ) as of Oct 16, 2026 is 184.45 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 183.12 M CNY — a change of 0.73% (higher).

EBITDA

184.45 MCNY

YoY

0.73%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SonoScape Medical is 2025 184.45 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SonoScape Medical was 2024 183.12 M CNY. It decreases by 0.73% higher compared to the previous year.

The SonoScape Medical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
287.23 M CNY
Jan 1, 2019
108.06 M CNY
Jan 1, 2020
161.87 M CNY
Jan 1, 2021
241.79 M CNY
Jan 1, 2022
409.09 M CNY
Jan 1, 2023
514.18 M CNY
Jan 1, 2024
183.12 M CNY
Jan 1, 2025
184.45 M CNY
The SonoScape Medical EBITDA history
YEAREBITDAYoY
184.45 MCNY+0.73%
183.12 MCNY-64.39%
514.18 MCNY+25.69%
409.09 MCNY+69.20%
241.79 MCNY+49.37%
161.87 MCNY+49.79%
108.06 MCNY-62.38%
287.23 MCNY+34.36%
213.78 MCNY+152.67%
84.61 MCNY+4.55%
80.93 MCNY-35.16%
124.81 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SonoScape Medical Stock analysis

What does SonoScape Medical do? SonoScape Medical Corp is a company based in Shenzhen, China, operating within the Health Care sector. It focuses on the research and development, production, and sales of medical diagnostic equipment. The company has a workforce of 2,334 employees. SonoScape Medical Corp completed its initial public offering (IPO) on April 6, 2017. Its primary products include medical ultrasound diagnostic equipment, such as color Doppler ultrasound systems and B-type ultrasound devices, as well as medical electronic endoscopes and related consumables, and blood analyzers. The company's headquarters are located in Shenzhen, Guangdong, and it maintains a corporate website at https://www.sonoscape.com/. SonoScape Medical Corp operates in the health care industry, providing diagnostic tools used in medical settings for patient assessment and treatment planning. The company's product portfolio emphasizes ultrasound technology, endoscopy, and laboratory equipment for blood analysis. It serves healthcare providers and facilities globally, though specific market details are not provided. The company's operations are centered around the development and commercialization of diagnostic solutions for the medical field. SonoScape Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SonoScape Medical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SonoScape Medical is 184.45 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SonoScape Medical changed from 183.12 M CNY to 184.45 M CNY, representing a 0.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) SonoScape Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s SonoScape Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — SonoScape Medical

All Key Metrics — SonoScape Medical